Drug Profile
Adrogolide
Alternative Names: ABT 431; DAS-431Latest Information Update: 30 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer Abbott Laboratories; DrugAbuse Sciences
- Class Antiparkinsonians
- Mechanism of Action Dopamine D1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cocaine-related disorders; Cognition disorders; Parkinson's disease